Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Astrocytoma
Drug:
thioguanine
(
DNA synthesis inhibitor
)
Regimen:
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
06/02/2022
Excerpt:
Recurrent or Progressive Disease...Useful in certain circumstances....Pilocytic astrocytomas...Thioguanine + PCV (category 2B)
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.